Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
483 participants
INTERVENTIONAL
2011-05-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active
Product 33525
33525
Daily dosing
Placebo
Product 33525 Placebo
Placebo
Daily dosing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
33525
Daily dosing
Placebo
Daily dosing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medicis Global Service Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ron Staugaard
Role: STUDY_DIRECTOR
Medicis Pharmaceutical
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fremont, California, United States
Los Angeles, California, United States
Miami, Florida, United States
Miramar, Florida, United States
St. Petersburg, Florida, United States
Evansville, Indiana, United States
Warren, Michigan, United States
Paramus, New Jersey, United States
Albuquerque, New Mexico, United States
Cincinnati, Ohio, United States
Philadelphia, Pennsylvania, United States
Goodletsville, Tennessee, United States
Austin, Texas, United States
College Station, Texas, United States
Plano, Texas, United States
San Antonio, Texas, United States
Lynchburg, Virginia, United States
Belize City, , Belize
San Salvador, , El Salvador
San Pedro Sula, , Honduras
Cidra, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MP-1000-01
Identifier Type: -
Identifier Source: org_study_id